微气泡/超音波显影剂市场规模、份额及成长分析（依产品类型、应用领域、最终用户、给药途径及地区）－2025-2032 年产业预测

全球微气泡/超音波显影剂市场规模预计在 2023 年达到 25 亿美元，到 2032 年将从 2024 年的 26.2 亿美元增长至 37.5 亿美元，预计在预测期内（2025-2032 年）的复合年增长率为 4.6%。

在医学影像中，显影剂，特别是微气泡，在诊断过程中对增强液体和结构的可见性起着关键作用。这些微气泡显影剂用于放射学和循环系统，可作为血池剂，并可用于基因治疗和分子成像等应用。利用疾病特异性配体，微气泡可以辨识血管生物标记、监测发炎和评估肿瘤血管。当静脉注射时，这些药物会模仿红血球并根据超音波频率改变大小，从而从目标组织区域产生强烈的迴声。这种增强的迴声增强提高了超音波分辨率，从而产生更清晰、更具资讯量的超音波心动图，并提高了医学影像的诊断准确性和患者预后。

目录

介绍

• 调查目的
• 研究范围
• 定义

调查方法

• 资讯采购
• 二次资料和一次资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分机会分析

市场动态与展望

• 市场概览
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特的分析

关键市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 市场吸引力指数（2024年）
• PESTEL分析
• 总体经济指标
• 价值链分析
• 定价分析

微气泡/超音波显影剂市场规模（依产品类型及复合年增长率）（2025-2032）

• 市场概览
• Definity
• Optison
• Sonovue
• Lumason
• 其他的

微气泡/超音波显影剂市场规模（依应用领域及复合年增长率）（2025-2032）

• 市场概览
• 心臟病学
• 肿瘤学
• 妇科
• 其他的

微气泡/超音波显影剂市场规模（按最终用户和复合年增长率划分）（2025-2032）

• 市场概览
• 医院
• 诊断影像中心
• 专科诊所
• 研究和学术机构

微气泡/超音波显影剂市场规模（依给药途径及复合年增长率）（2025-2032）

• 市场概览
• 静脉
• 血管内
• 动脉内
• 其他的

微气泡/超音波显影剂市场规模（按地区）及复合年增长率（2025-2032）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前五大公司对比
• 主要企业市场定位（2024年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市场占有率分析（2024年）
• 主要企业简介
  • 公司详情
  • 产品系列分析
  • 公司分部份额分析
  • 收益与前一年同期比较对比（2022-2024 年）

主要企业简介

• Bracco Imaging SpA（Italy）
• GE Healthcare（USA）
• Lantheus Holdings, Inc.（USA）
• FUJIFILM VisualSonics, Inc.（Canada）
• Siemens Healthineers AG（Germany）
• Canon Medical Systems Corporation（Japan）
• Samsung Medison Co., Ltd.（South Korea）
• Mindray Bio-Medical Electronics Co., Ltd.（China）
• Philips Healthcare（Netherlands）
• Advanced Microbubbles Laboratories BV（Netherlands）
• Targeson, Inc.（USA）
• VisualSonics（Canada）
• NanoMedical Diagnostics, Inc.（USA）
• Medtron AG（Germany）
• Insightec Ltd.（Israel）
• SuperSonic Imagine SA（France）
• Telemed Ultrasound Systems（Lithuania）

结论和建议

Global Microbubbles/Ultrasound Contrast Agents Market size was valued at USD 2.5 billion in 2023 and is poised to grow from USD 2.62 billion in 2024 to USD 3.75 billion by 2032, growing at a CAGR of 4.6% during the forecast period (2025-2032).

In the medical imaging sector, contrast media, particularly microbubbles, play a pivotal role in enhancing the visibility of fluids and structures during diagnostic procedures. Employed in radiology and cardiology, these microbubble contrast agents serve as blood pool agents and are instrumental in applications including gene therapy and molecular imaging. Utilizing disease-specific ligands, microbubbles can identify vascular biomarkers, monitor inflammation, and evaluate tumor vasculature. When injected intravenously, these agents mimic red blood cells, responding to ultrasound frequencies by altering their size and producing strong echoes from targeted tissue areas. This increased echogenicity improves ultrasound resolution, resulting in clearer and more informative echocardiograms, thus advancing diagnostic accuracy and patient outcomes in medical imaging.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Microbubbles/Ultrasound Contrast Agents market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Microbubbles/Ultrasound Contrast Agents Market Segments Analysis

Global Microbubbles/Ultrasound Contrast Agents Market is segmented by Product Type, Application Area, End-user, Route of Administration and region. Based on Product Type, the market is segmented into Definity, Optison, Sonovue, Lumason and Others. Based on Application Area, the market is segmented into Cardiology, Oncology, Gynecology and Others. Based on End-user, the market is segmented into Hospitals, Diagnostic Imaging Centers, Specialty Clinics and Research and Academic Institutes. Based on Route of Administration, the market is segmented into Intravenous, Intravascular, Intra-arterial and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Microbubbles/Ultrasound Contrast Agents Market

The Global Microbubbles and Ultrasound Contrast Agents market is gaining momentum due to several key factors. The increasing demand for targeted therapies and the necessity to track biomarker progression within the vascular endothelium are fueling the adoption of these technologies in molecular imaging. Additionally, advancements in ultrasound technology, coupled with a rising demand for precise diagnostic tools, are expected to drive the market forward during the forecast period. The superior benefits offered by microbubbles and ultrasound contrast agents compared to traditional diagnostic methods, alongside a growing prevalence of chronic diseases, are also contributing significantly to the market's anticipated growth trajectory.

Restraints in the Global Microbubbles/Ultrasound Contrast Agents Market

The global market for microbubbles and ultrasound contrast agents faces a significant challenge due to the relatively short lifespan of microbubbles, which poses a considerable limitation on their effectiveness and application. This inherent drawback is likely to hinder the growth and development of the market throughout the forecast period, as the limited duration of microbubble functionality can impact their usability in medical imaging and diagnostics. As a result, the industry may experience slowed progress and reduced adoption rates for these technologies unless solutions are found to enhance the stability and longevity of microbubbles in clinical settings.

Market Trends of the Global Microbubbles/Ultrasound Contrast Agents Market

The global microbubbles/ultrasound contrast agents market is witnessing a significant trend towards the integration of advanced molecular imaging capabilities, particularly in the fields of cardiology and radiology. As the technology evolves, microbubbles are increasingly being recognized not just as blood-pool agents but as versatile targeted agents capable of binding to disease-specific molecular markers through functionalization. This advancement allows for enhanced visualization of critical clinical conditions, such as tumor vasculature, vascular endothelium biomarker status, and inflammatory responses associated with ischemia-reperfusion injuries. Consequently, the market is poised for growth, driven by rising demand for precision diagnostics and personalized medicine.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Microbubbles/Ultrasound Contrast Agents Market Size by Product Type & CAGR (2025-2032)

• Market Overview
• Definity
• Optison
• Sonovue
• Lumason
• Others

Global Microbubbles/Ultrasound Contrast Agents Market Size by Application Area & CAGR (2025-2032)

• Market Overview
• Cardiology
• Oncology
• Gynecology
• Others

Global Microbubbles/Ultrasound Contrast Agents Market Size by End-user & CAGR (2025-2032)

• Market Overview
• Hospitals
• Diagnostic Imaging Centers
• Specialty Clinics
• Research and Academic Institutes

Global Microbubbles/Ultrasound Contrast Agents Market Size by Route of Administration & CAGR (2025-2032)

• Market Overview
• Intravenous
• Intravascular
• Intra-arterial
• Others

Global Microbubbles/Ultrasound Contrast Agents Market Size & CAGR (2025-2032)

• North America (Product Type, Application Area, End-user, Route of Administration)
  • US
  • Canada
• Europe (Product Type, Application Area, End-user, Route of Administration)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Application Area, End-user, Route of Administration)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Application Area, End-user, Route of Administration)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Application Area, End-user, Route of Administration)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Bracco Imaging S.p.A. (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GE Healthcare (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lantheus Holdings, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• FUJIFILM VisualSonics, Inc. (Canada)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthineers AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Canon Medical Systems Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Samsung Medison Co., Ltd. (South Korea)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mindray Bio-Medical Electronics Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Philips Healthcare (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Advanced Microbubbles Laboratories B.V. (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Targeson, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• VisualSonics (Canada)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• NanoMedical Diagnostics, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtron AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Insightec Ltd. (Israel)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SuperSonic Imagine S.A. (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Telemed Ultrasound Systems (Lithuania)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations